Nevro (NYSE:NVRO – Get Rating) released its earnings results on Wednesday. The medical equipment provider reported ($0.98) EPS for the quarter, topping analysts’ consensus estimates of ($1.06) by $0.08, Briefing.com reports. The company had revenue of $96.33 million during the quarter, compared to analysts’ expectations of $95.35 million. Nevro had a net margin of 0.74% […]
Nevro Corp. (NYSE:NVRO – Get Rating) – Research analysts at William Blair issued their Q1 2024 earnings per share estimates for Nevro in a report released on Thursday, April 20th. William Blair analyst B. Vazquez expects that the medical equipment provider will post earnings of ($0.80) per share for the quarter. The consensus estimate for […]
Nevro (NYSE:NVRO – Get Rating) had its price target reduced by stock analysts at Truist Financial from $42.00 to $40.00 in a report released on Monday, The Fly reports. Truist Financial’s price objective indicates a potential upside of 9.11% from the company’s previous close. Several other analysts also recently issued reports on the company. Piper […]
Analysts at Mizuho began coverage on shares of Nevro (NYSE:NVRO – Get Rating) in a research report issued on Thursday, The Fly reports. The brokerage set a “neutral” rating on the medical equipment provider’s stock. NVRO has been the subject of several other reports. Canaccord Genuity Group boosted their price target on Nevro from $67.00 […]